Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,013 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

NCT05665530

Conditions
Acute Myeloid Leukemia (AML), Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL), Bone Marrow Diseases, +41 more
Locations
  • City of Hope Duarte, California, United States
  • American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States
View all 24 locations
View Trial Details
Completed

Vaccine Immune Recovery After Leukemia

NCT05622682

Conditions
Acute Lymphoblastic Leukemia, Pediatric, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Helen DeVos Children's Hospital Grand Rapids, Michigan, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Monroe Carell Jr. Children's Hospital at Vanderbilt Nashville, Tennessee, United States
View Trial Details
Completed

Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

NCT04139434

Conditions
AML/MDS, CMML, Disease Attributes, +20 more
Locations
  • University of Michigan Ann Arbor, Michigan, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • Ohio State Comprehensive Cancer Center Columbus, Ohio, United States
  • MD Anderson Cancer Center Huston, Texas, United States
View Trial Details
Completed

Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

NCT04593277

Conditions
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +38 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions